Linda Castaldo
Publications by Year
Research Areas
Cancer Mechanisms and Therapy, Enzyme function and inhibition, Nuclear Receptors and Signaling, PI3K/AKT/mTOR signaling in cancer, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → ROCK1 and ROCK2 Are Required for Non-Small Cell Lung Cancer Anchorage-Independent Growth and Invasion(2012)136 cited
- → OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models(2006)80 cited
- → Temporal quantitation of mutant Kit tyrosine kinase signaling attenuated by a novel thiophene kinase inhibitor OSI-930(2005)45 cited
- → Quantitative High‐Throughput Cell‐Based Assays for Inhibitors of ROCK Kinases(2008)10 cited
- → Supplementary Methods, Table 1, Figures 1-3 from ROCK1 and ROCK2 Are Required for Non-Small Cell Lung Cancer Anchorage-Independent Growth and Invasion(2023)
- → Supplementary Figures 1-3 from OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models(2023)
- → Supplementary Figure Legends from OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models(2023)
- → Data from ROCK1 and ROCK2 Are Required for Non-Small Cell Lung Cancer Anchorage-Independent Growth and Invasion(2023)